ARCHIVES

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | April 26, 1974

Download PDF Visit The Full Archive

Related Articles

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

NCI program announcement available, contract awards listed.

November 14, 2003

DeVita Reshuffling NCI Office Space

April 18, 1980

DCPC Developing Hispanic Cancer Control Intervention Program Concept

August 12, 1988

HHS Inspector General: IRBs Vulnerable In Changing Research Environment-Report

July 10, 1998